Cargando…

Which low‐dose atropine for myopia control?

Detalles Bibliográficos
Autores principales:	Khanal, Safal, Phillips, John R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2019
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065125/ https://www.ncbi.nlm.nih.gov/pubmed/31489714 http://dx.doi.org/10.1111/cxo.12967

Ejemplares similares

Topical Atropine in the Control of Myopia
por: GALVIS, Virgilio, et al.
Publicado: (2016)

The Combined Effect of Low-dose Atropine with Orthokeratology in Pediatric Myopia Control: Review of the Current Treatment Status for Myopia
por: Sánchez-González, José-María, et al.
Publicado: (2020)

Biological Mechanisms of Atropine Control of Myopia
por: Upadhyay, Aradhana, et al.
Publicado: (2020)

Update in myopia and treatment strategy of atropine use in myopia control
por: Wu, Pei-Chang, et al.
Publicado: (2018)

Compliance in usage of low-dose atropine for prevention of progression of myopia in Indian children
por: Dalal, Devanshi M, et al.
Publicado: (2021)

Efficacy of low-dose atropine to reduce myopia progression among Indian children
por: Sivaraman, Viswanathan, et al.
Publicado: (2021)

Hospital-prepared low-dose atropine eye drops for myopia progression control using atropine sulfate injection diluted in normal saline and lubricants
por: Wongwirawat, Nuthida, et al.
Publicado: (2022)

Overnight orthokeratology is comparable with atropine in controlling myopia
por: Lin, Hui-Ju, et al.
Publicado: (2014)

Low-Concentration Atropine Eye Drops for Myopia Progression
por: Li, Fen Fen, et al.
Publicado: (2019)

Stability of Ophthalmic Atropine Solutions for Child Myopia Control
por: Berton, Baptiste, et al.
Publicado: (2020)

Role of Atropine in the control of Myopia Progression- A Review
por: Kaiti, Raju, et al.
Publicado: (2022)

Efficacy Comparison of Repeated Low-Level Red Light and Low-Dose Atropine for Myopia Control: A Randomized Controlled Trial
por: Chen, Yanxian, et al.
Publicado: (2022)

Efficacy of 0.01% low dose atropine and its correlation with various factors in myopia control in the Indian population
por: Chaurasia, Shweta, et al.
Publicado: (2022)

Myopia Control with Combination Low-Dose Atropine and Peripheral Defocus Soft Contact Lenses: A Case Series
por: Erdinest, Nir, et al.
Publicado: (2021)

Effectiveness study of atropine for progressive myopia in Europeans
por: Polling, J R, et al.
Publicado: (2016)

Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: The Atropine for Children and Adolescent Myopia Progression Study
por: Ye, Luyao, et al.
Publicado: (2022)

Risk factors for rapid axial length elongation with low concentration atropine for myopia control
por: Fu, Aicun, et al.
Publicado: (2021)

The Role of Atropine in Preventing Myopia Progression: An Update
por: Chierigo, Alberto, et al.
Publicado: (2022)

Effect of atropine 0.01% on progression of myopia
por: Sen, Snigdha, et al.
Publicado: (2022)

Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release
por: Thomson, Kate, et al.
Publicado: (2021)

Myopia control utilizing low-dose atropine as an isolated therapy or in combination with other optical measures: A retrospective cohort study
por: Erdinest, Nir, et al.
Publicado: (2022)

Atropine 0.5% eyedrops for the treatment of children with low myopia: A randomized controlled trial
por: Wang, Yan-rong, et al.
Publicado: (2017)

Consensus statement and guidelines for use of dilute atropine sulphate in myopia control
por: Kesarwani, Siddharth S
Publicado: (2019)

Retarding Progression of Myopia with Seasonal Modification of Topical Atropine
por: Lu, Paul CS, et al.
Publicado: (2010)

The Synergistic Effects of Orthokeratology and Atropine in Slowing the Progression of Myopia
por: Wan, Lei, et al.
Publicado: (2018)

A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine
por: Nucci, Paolo, et al.
Publicado: (2023)

Additive effect of atropine eye drops and short-term retinal defocus on choroidal thickness in children with myopia
por: Chiang, Samuel T.-H., et al.
Publicado: (2020)

Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

The Effectiveness and Tolerability of Atropine Eye Drops for Myopia Control in Non-Asian Regions
por: Simonaviciute, Dovile, et al.
Publicado: (2023)

Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials
por: Kumari, Shalini, et al.
Publicado: (2022)

Myopia Control with Low-Dose Atropine in European Children: Six-Month Results from a Randomized, Double-Masked, Placebo-Controlled, Multicenter Study
por: Hvid-Hansen, Anders, et al.
Publicado: (2023)

Effects of atropine 0.01% on refractive errors in children with myopia
por: Zhu, Xingxue, et al.
Publicado: (2023)

A STROBE-compliant case–control study: Effects of cumulative doses of topical atropine on intraocular pressure and myopia progression
por: Yu, Teng-Chieh, et al.
Publicado: (2020)

Low-dose AtropIne for Myopia Control in Children (AIM): protocol for a randomised, controlled, double-blind, multicentre, clinical trial with two parallel arms
por: Farassat, Navid, et al.
Publicado: (2023)

Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis
por: Zhao, Congling, et al.
Publicado: (2020)

Allergic reactions to atropine eye drops for retardation of progressive myopia in children
por: Kothari, Mihir, et al.
Publicado: (2018)

Nitric Oxide (NO) Mediates the Inhibition of Form-Deprivation Myopia by Atropine in Chicks
por: Carr, Brittany J., et al.
Publicado: (2016)

Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children
por: Zhao, Qi, et al.
Publicado: (2020)

Corneal Penetration of Low-Dose Atropine Eye Drops
por: Austermann, Henning, et al.
Publicado: (2021)

Commentary: Low-dose atropine: How clear is the view?
por: Chaturvedi, Isha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5sk46vieqdcht3dpv7tvf3j2u4